With a market cap of $74.3 billion, CRH plc (CRH) is a leading provider of building materials and infrastructure solutions, serving customers across Ireland, the United States, the United Kingdom, Europe, and other international markets. It supplies a broad range of construction materials and products, including aggregates, cement, ready-mixed concrete, asphalt, and precast concrete solutions for residential, commercial, and public infrastructure projects.
Companies valued more than $10 billion are generally considered “large-cap” stocks, and CRH fits this criterion perfectly. CRH supports the development and maintenance of transportation networks, utility infrastructure, buildings, and outdoor living spaces worldwide.
Shares of the Dublin, Ireland-based company have decreased nearly 15% from its 52-week high of $131.55. Over the past three months, its shares have soared 11.4%, lagging behind the broader S&P 500 Index’s ($SPX) nearly 14.8% gain during the same period.
CRH stock is down 10.3% on a YTD basis, underperforming SPX's 9.1% rise. However, shares of the company have returned nearly 27% over the past 52 weeks, outpacing the 25.2% return of the SPX over the same time frame.
Despite recent fluctuations, the stock has been trading below its 50-day and 200-day moving averages since early May.
Shares of CRH rose 4.4% on Apr. 30 after the company reported stronger-than-expected Q1 2026 results, with total revenue increasing 9% year-over-year to $7.4 billion and adjusted EBITDA rising 18% to $600 million, while EBITDA margin improved to 8%. Investor sentiment was further boosted by CRH reaffirming its full-year 2026 guidance, including expected net income of $3.9 billion to $4.1 billion and adjusted EBITDA of $8.1 billion to $8.5 billion.
In comparison, rival Vulcan Materials Company (VMC) has outpaced CRH stock on a YTD basis, with VMC stock gaining 7.4%. Nevertheless, VMC stock has increased 19.6% over the past 52 weeks, lagging behind CRH stock.
Due to the stock’s outperformance over the past year, analysts remain bullish about its prospects. CRH stock has a consensus rating of “Strong Buy” from 21 analysts in coverage, and the mean price target of $146 is a premium of 30.6% to current levels.
